Trial supports using clot-busting drug in late window after acute ischemic stroke
UC expert featured in TCT MD article
The University of Cincinnati's Eva Mistry spoke with TCT MD about new trial data that found administering the clot-busting drug alteplase is beneficial for patients with acute ischemic stroke and salvageable brain tissue on imaging up to 24 hours after symptom onset.
Results of the HOPE trial, published online last week in the journal JAMA, found 40.3% of patients treated with alteplase were functionally independent at 90 days after a stroke, while 26.3% of patients who received standard care were functionally independent. The alteplase group had a higher up-front rate of symptomatic intracranial hemorrhage, but there was no difference in 90-day mortality.
“These findings support extending the therapeutic window for IV thrombolysis in appropriately selected patients when endovascular thrombectomy is not initially planned or indicated,” the researchers concluded.
Mistry said these results are mostly applicable in places where thrombectomy isn't readily available. Thrombectomy is a minimally invasive stroke procedure that uses a catheter to remove a blood clot from a blood vessel in the brain to restore blood flow.
“That still concerns me in terms of generalizability of the results outside of resource-poor settings where thrombectomy isn’t available,” said Mistry, MBBS, associate professor in UC's College of Medicine and a UC Gardner Neuroscience Institute physician. In low-to-middle-income countries with insufficient resources, long transfer times, and/or no thrombectomy services, on the other hand, she said it is encouraging “that now, patients may be considered for a reperfusion therapy based on advanced imaging selection in the extended time window.”
Featured photo at top of Mistry, left, and Stacie Demel, DO. Photo/Andrew Higley/UC Marketing + Brand.
Related Stories
CCM welcomes new film and media scoring faculty member J.R. Paredes
May 20, 2026
UC College-Conservatory of Music Dean Pete Jutras has announced the appointment of J.R. Paredes as CCM's new Assistant Professor of Film and Media Scoring. His faculty appointment officially begins on Aug. 15, 2026. Paredes is a composer, music producer and audio post-production specialist whose work spans film, television and commercial music. His credits include original scores for feature films and series distributed on platforms such as Apple TV+ and Prime Video, as well as extensive work in sound design and mixing for film and media.
6 ways starting a GLP-1 medication could affect your emotions
May 20, 2026
When patients first start taking a glucagon-like peptide-1 (GLP-1) medication, they probably expect to feel full. But they might not anticipate how it can influence their emotions. The medications act on the stomach and the brain, said Malti Vij, MD, a University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine and a diplomate of the American Board of Obesity Medicine.